Transmission of hepatitis C virus infection in hemodialysis: Current concepts

International Journal of Artificial Organs

Volumn 31, Issue 12, 2008, Pages 1004-1016

  Fabrizi, Fabrizio ^a,b   Messa, P ^a   Martin, P ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Hemodialysis; Hepatitis C; Isolation; Nosocomial transmission

Indexed keywords

CONTAMINATION; HEMODIALYZERS; NUCLEIC ACIDS; PATIENT TREATMENT; VIRUSES;

CONTROL PROCEDURES; DIALYSIS MACHINES; HAEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; INFECTION CONTROL; ISOLATION; NOSOCOMIAL TRANSMISSION; VIRUS INFECTION;

DIALYSIS;

HEPATITIS B SURFACE ANTIGEN; VIRUS RNA;

ANTIBODY DETECTION; ANTIGEN DETECTION; ARTIFICIAL KIDNEY; BLOOD ANALYSIS; BLOOD TRANSFUSION; BODY FLUID; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EPIDEMIOLOGICAL DATA; GENE SEQUENCE; GENETIC SCREENING; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HOSPITAL PERSONNEL; HOSPITAL POLICY; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; NONHUMAN; PATIENT CARE; PERSONAL HYGIENE; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEROCONVERSION; SEROLOGY; SEROPREVALENCE; TREATMENT DURATION; ULTRAFILTRATION; VERTICAL TRANSMISSION; VIRAL CONTAMINATION; VIROLOGY; VIRUS GENOME; VIRUS ISOLATION; VIRUS TRANSMISSION;

EID: 60749136330     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803101204     Document Type: Review

References (107)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-61.
2. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-4.
3. Kidney Disease Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int 2008; 73 (Suppl 109): S1-99.
4. Sivapalasingam S, Malak SF, Sullivan JF, Lorch J, Sepkowitz KA. High prevalence of hepatitis C infection among patients receiving hemodialysis at an urban dialysis center. Infect Control Hosp Epidemiol 2002; 23: 319-24.
5. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18: 52-61.
6. Jadoul M, Poignet JL, Geddes C, et al; HCV Collaborative Group. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 2004; 19: 904-9.
7. Fissell RB, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004; 65: 2335-42.
8. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002; 36: 3-10.
9. Todorov V, Boneva R, Ilieva P, Doichinova T, Donchev M. High prevalence of hepatitis C virus infection in one dialysis center in Bulgaria [letter]. Nephron 1998; 79: 222-3.
10. Hassan AA, Khalili R. Hepatitis C in dialysis patients in Egypt: relationship to dialysis duration, blood transfusion, and liver disease. Saudi J Kidney Dis Transplant 2000; 11: 72-5.
11. El-Hamin HH, Osman EM, Mekki MO, et al. Hepatitis C virus infection in hemodialysis patients in Sudan: two centers' report. Saudi J Kidney Dis Transplant 2007; 18: 101-6.
12. Sekkat S, Kamal N, Benali B, et al. Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco. Nephrol Ther 2008; 4: 105-10.
13. Fabrizi F, Bacchini G, Pontoriero G, Guarnori I, Erba G, Locatelli F. Antibodies to hepatitis C virus and transaminase concentration in chronic haemodialysis patients: a study with second-generation assays. Nephrol Dial Transplant 1993; 8: 744-7.
14. Hardy NM, Sandroni S, Danielson S, Winson WJ. Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol 1992; 38: 44-8.
15. Pujiol FH, Ponce IG, Lema MG, et al. High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. J Clin Microbiol 1996; 34: 1633-6.
16. Chan TM, Lok ASF, Cheng IK. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance hemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991; 6: 944-7.
17. Fabrizi F, Lunghi G, Guarnori I, et al. Hepatitis C virus genotypes in chronic dialysis patients. Nephrol Dial Transplant 1996; 11: 679-83.
18. Allander TG, Gruber A, Naghavi M, et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995; 345: 603-7.
19. Ou CY, Ciesielski CA, Myers G, et al; Laboratory Investigation Group, Epidemiologic Investigation Group. Molecular epidemiology of HIV transmission in a dental practice. Science 1992; 256: 1165-71.
20. Berger H, Weiser B, Flaherty K, Gulla J, Nguyen PN, Gibbs RA. Evolution of human immunodeficiency virus type 1 nucleotide sequence diversity among close contacts. Proc Natl Acad Sci U S A 1991; 88: 11336-440.
21. Allander T, Medin C, Jacobson SH, Grillner L, Persson MA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994; 43: 415-9.
22. Stuyver L, Claeys H, Wyseur A, et al. Hepatitis C virus in a hemodialysis unit: molecular evidence for nosocomial transmission. Kidney Int 1996; 49: 889-95.
23. Zeuzem S, Scheuermann EH, Waschk D, et al. Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients. Kidney Int 1996; 49: 896-902.
24. De Lamballerie X, Olmer M, Bouchouareb D, Zandotti C, De Micco P. Nosocomial transmission of hepatitis C virus in haemodialysis patients. J Med Virol 1996; 49: 296-302.
25. McLaughlin KJ, Cameron SO, Good T, et al. Nosocomial transmission of hepatitis C virus within a British dialysis centre. Nephrol Dial Transplant 1997; 12: 304-9.
26. Mizuno M, Higuchi T, Kanmatsuse K, Esumi M. Genetic and serological evidence for multiple instances of unrecognised transmission of hepatitis C virus in hemodialysis units. J Clin Microbiol 1998; 36: 2926-31.
27. Le Pogam S, Le Chapois D, Christen R, Dubois F, Barin F, Goudeau A. Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission. J Clin Microbiol 1998; 36: 3043-6.
28. Irish DN, Blake C, Christophers J, et al. Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: implications for infection control and laboratory screening. J Med Virol 1999; 59: 135-40.
29. Katsoulidou A, Paraskevis D, Kalapothaki V, et al. Molecular epidemiology of a hepatitis C virus outbreak in a haemo1014 dialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 1999; 14: 1188-94.
30. Izopet J, Pasquier C, Sandres K, Puel J, Rostaing L. Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J Med Virol 1999; 58: 139-44.
31. Abacioglu YH, Bacaksiz F, Bahar IH, Simmonds P. Molecular evidence of nosocomial transmission of hepatitis C virus in a hemodialysis unit. Eur J Clin Microbiol Infect Dis 2000; 19: 182-6.
32. Schneeberger PM, Doorenbos CJ, van der Vliet W, Bergervoet P, Quint W, van Doorn LJ. Nosocomial transmission of hepatitis C virus in a Dutch dialysis center. Ned Tijdschr Geneeskd 1999; 143: 801-6.
33. Grethe S, Gemsa F, Monazahian M, Bohme I, Uy A, Thomssen R. Molecular epidemiology of an outbreak of HCV in a hemodialysis unit: Direct sequencing of HCV-HVR1 as an appropriate tool for phylogenetic analysis. J Med Virol 2000; 60: 152-8.
34. Hosokawa N, Esumi M, Iwasaki Y, Yanai M, Enomoto A, Kawano K. Phylogenetic evidence, by multiple clone analysis of hypervariable region 1, for the transmission of hepatitis C virus to chronic haemodialysis patients. J Viral Hepat 2000; 7: 276-82.
35. Kokubo S, Horii T, Yonekawa O, Ozawa N, Mukaide M. A phylogenetic-tree analysis elucidating nosocomial transmission of hepatitis C virus in a haemodialysis unit. J Viral Hepat 2002; 9: 450-4.
36. Delarocque-Astagneau E, Baffoy N, Thiers V, et al. Outbreak of hepatitis C virus infection in a hemodialysis unit: potential transmission by the hemodialysis machine ? Infect Control Hosp Epidemiol 2002; 23: 328-34.
37. Halfon P, Roubicek C, Gerolami V, et al. Use of phylogenetic analysis of hepatitis C virus hypervariable region 1 sequences to trace an outbreak of HCV in an autodialysis unit. J Clin Microbiol 2002; 40; 1541-5.
38. Ansaldi F, Bruzzone B, de Florentiis D, et al. An outbreak of hepatitis C virus in a hemodialysis unit: molecular evidence of patient-to-patient transmission. Ann Ig 2003; 15: 685-91.
39. Furusyo N, Kubo N, Nakashima H, Kashiwagi K, Etoh Y, Hayashi J. Confirmation of nosocomial hepatitis C virus infection in a hemodialysis unit. Control Hosp Epidemiol 2004; 25: 584-90.
40. Sartor C, Brunet P, Simon S, Tamalet C, Berland Y, Drancourt M. Transmission of hepatitis C virus between hemodialysis patients sharing the same machine. Infect Control Hosp Epidemiol 2004; 25: 609-11.
41. Izopet J, Sandres-Saune K, Kamar N, et al. Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol 2005; 77: 70-6.
42. Castell J, Gutierrez G. Outbreak of 18 cases of hepatitis C in a hemodialysis unit. Gac Sanit 2005; 19: 214-20.
43. Savey A, Simon P, Izopet J, Lepoutre A, Fabry J, Desenclos JC. A large nosocomial outbreak of hepatitis C virus infections at a hemodialysis center. Infect Control Hosp Epidemiol 2005; 26: 752-60.
44. Bracho MA, Gosalbes MJ, Blasco D, Moya A, Gonzalez-Candelas F. Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit. J Clin Microbiol 2005; 43: 2750-5.
45. Kondili LA, Genovese D, Argentini C, et al. Nosocomial transmission in simultaneous outbreaks of hepatitis C and B virus infections in a hemodialysis center. Eur J Clin Microbiol Infect Dis 2006; 25: 527-31.
46. Hmaied F, Ben Mamou M, Dubois M, et al. Determining the source of nosocomial transmission in hemodialysis units in Tunisia by sequencing NS5B and E2 sequences of HCV. J Med Virol 2007; 79: 1089-94.
47. Spada E, Abbate I, Sicurezza E, et al. Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit in Italy. J Med Virol 2008; 80: 261-7.
48. Sampietro M, Badalamenti S, Salvadori S, et al. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int 1995; 47: 911-7.
49. Seme K, Poljak M, Zuzec-Resek S, Debeljak M, Dovic P, Koren S. Molecular evidence for nosocomial spread of two different hepatitis C virus strains in one hemodialysis unit. Nephron 1997; 77: 273-8.
50. Olmer M, Bouchouareb D, Zandotti C, de Micco P, de Lamballerie X. Transmission of the hepatitis C virus in an hemodialysis unit: evidence for nosocomial infection. Clin Nephrol 1997; 47: 263-70.
51. Norder H, Bergstrom A, Uhnoo I, et al. Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region. J Clin Microbiol 1998; 36: 3066-9.
52. Munro J, Briggs JD, McCruden EA. Detection of a cluster of hepatitis C infections in a renal transplant unit by analysis of sequence variation of the NS5a gene. J Infect Dis 1996; 174: 177-80.
53. Kellerman S, Alter MJ. Preventing hepatitis B and C virus infections in end-stage renal disease patients: back to basics. Hepatology 1999; 29: 291-3.
54. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47 (No. RR-19): 1-39.
55. Vagelli G, Calabrese G, Guaschino R, Gonella M. Effect of HCV positive patient isolation on HCV infection incidence in a dialysis unit. Nephrol Dial Transplant 1995; 1070-1.
56. Arenas Jiménez MD, Sanchez-Paya J, Gonzalez C, Rivera F, Enriquez R. Isolation of HCV patient is efficient in reducing the annual incidence of HCV infection, but is it really necessary ? Nephrol Dial Transplant 1999; 14: 1337-9.
57. Djordjevic V, Stojanovic K, Stojanovic M, Stefanovic V. Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit: a prospective study. Int J Artif Organs 2000; 23: 181-8.
58. Harmankaya O, Cetin B, Erimez D, Obek A, Seber E. Patient isolation prevents the transmission of hepatitis C virus infection in hemodialysis units. Dial Transplant 2002; 31: 859-61.
59. Saxena AK, Panhotra BR, Sundaram DS, et al. Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unit of the middle east. Am J Infect Control 2003; 31: 26-33.
60. Gallego E, Lopez A, Perez J, et al. Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis. Nephron Clin Pract 2006; 104: c1-6.
61. Petrosillo N, Gilli P, Serraino D, et al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 2001; 37: 1004-10.
62. Kamili S, Krawczynski K, McCaustland K, Li X, Alter MJ. Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol 2007; 28: 519-24.
63. Widell A, Mansson S, Persson NH, Thysell H, Hermodsson S, Blohme I. Hepatitis C superinfection in hepatitis C virus (HCV) infected patients transplanted with an HCV-infected kidney. Transplantation 1995; 60: 642-7.
64. Natov S, Lau JY, Bouthot BA, et al; and The New England Organ Bank Hepatitis C Study Group. Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. Am J Kidney Dis 1998; 31: 920-7.
65. Schroeter M, Zoellner B, Polywka S, Laufs R, Feucht HH. Prolonged time until seroconversion among haemodialysis patients: the need for HCV PCR. Intervirology 2005; 48: 213-5.
66. Sypsa V, Psichogiou M, Katsoulidou A, et al. Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients. Am J Kidney Dis 2005; 45: 334-43.
67. Blumberg A, Zehnder C, Burckhardt JJ. Prevention of hepatitis C infection in haemodialysis units: a prospective study. Nephrol Dial Transplant 1995; 10: 230-3.
68. Dos Santos JP, Loureiro A, Cendoroglo Neto M, Pereira BJ. Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units. Nephrol Dial Transplant 1996; 11: 2017-22.
69. Taskapan H, Oymak O, Dogukan A, Utas C. Patient to patient transmission of hepatitis C virus in hemodialysis units. Clin Nephrol 2001; 55: 477-81.
70. Aucella F, Vigilante M, Valente GL, Stallone C. Systematic monitor disinfection is effective in limiting HCV spread in hemodialysis. Blood Purif 2000; 18: 110-4.
71. Cerrai T, Toti G, Michelassi S, Zignego AL, Lombardi M. Universal precautions and dedicated machines as cheap and effective measures to control HCV spread in haemodialysis centers. EDTNA/ERCA J 1997; XXIII: S1-14.
72. Broumand B, Shamshirsaz AA, Kamgar M, et al. Prevalence of hepatitis C infection and its risk factors in hemodialysis patients in Tehran: preliminary report from 'The effect of dialysis unit isolation on the incidence of hepatitis C in dialysis patients' project. Saudi J Kidney Dis Transplant 2002; 13: 467-72.
73. Shamshirsaz AA, Kamgar M, Bekheirnia MR, et al. The role of hemodialysis machines dedication in reducing hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study. BMC Nephrol 2004; 5: 13.
74. Gilli P, Soffritti S, De Paoli Vitali E, Bedani PL. Prevention of hepatitis C virus in dialysis units. Nephron 1995; 70: 301-6.
75. Jadoul M, Cornu C, van Ypersele de Strihou C. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int 1998; 53: 1022-5.
76. Valtuille R, Moretto H, Lef L, Rendo P, Fernandez H. Decline of high hepatitis C virus prevalence in a hemodialysis unit with no isolation measures during a 6-year follow-up. Clin Nephrol 2002; 57: 371-5.
77. Noiri E, Nakao A, Oya A, Fujita T, Kimura S. Hepatitis C virus in blood and dialysate in hemodialysis. Am J Kidney Dis 2001; 37: 38-42.
78. Castelnovo C, Sampietro M, de Vecchi A, et al. Diffusion of HCV through peritoneal membrane in HCV positive patients treated with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1997; 12: 978-80.
79. Krautzig S, Tillmann H, Wrenger E, Manns M, Koch KM. Hepatitis C virus (HCV) in peritoneal dialysis [letter]. Clin Nephrol 1994; 41: 120.
80. Sampietro M, Graziani G, Badalamenti S, et al. Detection of hepatitis C virus in dialysate and blood ultrafiltrate of HCVpositive patients [letter]. Nephron 1994; 68: 140.
81. Lombardi M, Cerrai T, Dattolo P, et al. Is the dialysis membrane a safe barrier against HCV infection? Nephrol Dial Transplant 1995; 10: 578-9.
82. Valtuille R, Fernandez JL, Berridi J, et al. Evidence of hepatitis C virus passage across dialysis membrane. Nephron 1998; 80: 194-6.
83. Hubmann R, Zazgornik J, Gabriel C, Garbeis B, Blauhut B. Hepatitis C virus: does it penetrate the haemodialysis membrane ? PCR analysis of haemodialysis ultrafiltrate and whole blood [letter]. Nephrol Dial Transplant 1995; 10: 541-2.
84. Gladziwa U, Schlipkoter U. Evidence of hepatitis C virus infection in peritoneal fluid but not in dialysate and ultrafiltrate or hemofiltrate [letter]. Nephron 1995; 71: 98.
85. Cusumano AM, Poratto F, del Pino N, Fernandez JL, Vilches A. Identification of hepatitis C virus RNA in peritoneal fluid of patients with viremia. Perit Dial Int 2005; 25: 478-82.
86. Caramelo C, Navas S, Alberola ML, Bermejillo T, Reyero A, Carreno V. Evidence again transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994; 66: 470-3.
87. Manzini P, Amore A, Bonaudo R, et al. Is HCV RNA detectable in the ultrafiltrate ? Minerva Urol Nefrol 1996; 48: 75-9.
88. Chiaramonte S, Tagger A, Ribero ML, Grossi A, Milan M, La Greca G. Prevention of viral hepatitis in dialysis units: isolation and technical management of dialysis. Nephron 1992; 61: 287-89.
89. Simon N, Couroucè AM, Lemarrec N, Trepo C, Ducamp S. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994; 46: 504-11.
90. Mitwalli A, Al-Mohaya S, Al Wakeel J, et al. Hepatitis C in chronic renal failure patients. Am J Nephrol 1992; 12: 288-91.
91. Hung KY, Chen WY, Yang CS, Lee SH, Wu DJ. Hepatitis B and C in hemodialysis patients. Dial Transplant 1995; 24: 135-9.
92. Lin HH, Huang CC, Sheen IS, Lin DY, Liaw YF. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit. Am J Nephrol 1991; 11: 192-4.
93. Kiyosawa K, Sodeyama T, Tanaka E, et al. Hepatitis C in hospital employees with needle stick injuries. Ann Intern Med 1991; 115: 367-9.
94. Cariani E, Zonato A, Primi D, Scalia P, Magni A, Incarbone C. Detection of HCV RNA and antibodies to HCV after needlestick injury [letter]. Lancet 1991; 337: 850.
95. Lombardi M, Cerrai T, Geatti S, et al. Results of a national epidemiological investigation on HCV infection among dialysis patients. J Nephrol 1999; 12: 322-7.
96. Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334: 555-60.
97. Okuda K, Hayashi H, Kobayashi S, Irie Y. Mode of hepatitis C infection not associated with blood transfusions among chronic hemodialysis patients. J Hepatol 1995; 23: 28-31.
98. Gilli P, Moretti M, Soffritti S, et al. Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Organs 1990; 13: 737-41.
99. Arenas Jiménez MD, Sánchez-Payá J. Standard precautions in haemodialysis: the gap between theory and practice. Nephrol Dial Transplant 1999; 14: 823-5.
100. Arenas Jiménez MD, Sanchez-Paya J, Gonzales C, Rivera F, Antolin A. Audit on the degree of application of universal precautions in a haemodialysis unit. Nephrol Dial Transplant 1999; 14: 1001-3.
101. Arenas Jiménez MD, Sanchez-Paya J, Barril G, et al. A multicentric survey of the practice of hand hygiene in haemodialysis unit: factors affecting compliance. Nephrol Dial Transplant 2005; 20: 1164-71.
102. Alfurayh O, Sabeel A, Al Ahdal MN, et al. Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients. Am J Nephrol 2000; 20: 103-6.
103. Froio N, Nicastri E, Comandini UV, et al. Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis 2003; 42: 546-50.
104. Niu MT, Alter JA, Kristensen C, Margolis HS. An outbreak of hemodialysis associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Am J Kidney Dis 1992; 19: 345-52.
105. Cendoroglo Neto M, Draibe SA, Silva AE, et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995; 10: 240-6.
106. Caramelo C, de Sequera P, Lopez MD, Ortiz A. Hand-borne mechanisms of dissemination of hepatitis C virus in dialysis units: basis for new addenda to the present preventive strategies [letter]. Clin Nephrol 1999; 51: 59-60.
107. Mangia A, Burra P, Ciancio A, et al; Italian Association for the Study of the Liver (AISF). Hepatitis C infection in patients with chronic kidney disease. Int J Artif Organs 2008; 31: 15-33.